Abstract
Transcatheter closure of VSD has been successful in defects of the muscular septum distant from the aortic and mitral valve apparatus. Attempts to close subaortic VSDs have been largely unsuccessful because of device-related aortic insufficiency. The NitOcclud device is a Nitinol spiral coil device which has been evaluated in animals with subaortic VSD. Results of the animal study are promising, and the device has also been implanted in a few humans. This paper describes the device, the implant technique in subaortic VSD, and the results of animal and human implants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
